DCF — SOUTH BALDWIN REGIONAL MEDICAL CENTE
Enterprise Value: $107.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$107.2M
Enterprise Value
$27.3M
PV of Cash Flows
$79.9M
PV of Terminal Value
$128.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $173.2M | $14.7M | 9.0% | $4.8M | $4.4M |
| Year 2 | $178.4M | $16.9M | 10.0% | $6.3M | $5.2M |
| Year 3 | $183.8M | $19.3M | 11.0% | $7.8M | $5.9M |
| Year 4 | $189.3M | $20.8M | 11.0% | $8.8M | $6.0M |
| Year 5 | $194.9M | $21.9M | 11.0% | $9.4M | $5.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $107.2M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$168.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000237872311
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5